Bank of Hawaii’s GSK GSK Stock Holding History

Bank of Hawaii’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,088	Closed	-$326K	–	266
2020 Q4	$326K	Sell	7,088 -31,356	-82%	-$1.44M	0.02%	227
2020 Q3	$1.81M	Sell	38,444 -1,951	-5%	-$97.8K	0.13%	97
2020 Q2	$2.06M	Sell	40,395 -2,665	-6%	-$137K	0.16%	82
2020 Q1	$2.04M	Buy	43,060 +430	+1%	+$22.9K	0.18%	72
2019 Q4	$2.5M	Buy	42,630 +718	+2%	+$39.9K	0.17%	78
2019 Q3	$2.24M	Sell	41,912 -414	-1%	-$21.3K	0.17%	86
2019 Q2	$2.12M	Buy	42,326 +2,836	+7%	+$142K	0.16%	90
2019 Q1	$2.06M	Buy	39,490 +200	+0.5%	+$9.99K	0.16%	94
2018 Q4	$1.88M	Buy	39,290 +2,809	+8%	+$138K	0.16%	93
2018 Q3	$1.83M	Buy	36,481 +1,121	+3%	+$57K	0.14%	108
2018 Q2	$1.78M	Buy	35,360 +4,794	+16%	+$241K	0.15%	103
2018 Q1	$1.49M	Sell	30,566 -585	-2%	-$27.2K	0.12%	116
2017 Q4	$1.38M	Sell	31,151 -6,811	-18%	-$315K	0.11%	133
2017 Q3	$1.93M	Sell	37,962 -24,396	-39%	-$1.24M	0.16%	102
2017 Q2	$3.36M	Sell	62,358 -5,974	-9%	-$318K	0.29%	65
2017 Q1	$3.6M	Sell	68,332 -26,740	-28%	-$1.36M	0.32%	61
2016 Q4	$4.58M	Sell	95,072 -26,835	-22%	-$1.33M	0.43%	55
2016 Q3	$6.57M	Sell	121,907 -3,703	-3%	-$203K	0.61%	44
2016 Q2	$6.8M	Sell	125,610 -279	-0.2%	-$14.7K	0.73%	35
2016 Q1	$6.38M	Sell	125,889 -8,720	-6%	-$434K	0.69%	37
2015 Q4	$6.79M	Buy	134,609 +11,855	+10%	+$604K	0.78%	35
2015 Q3	$5.9M	Buy	122,754 +6,907	+6%	+$360K	0.69%	41
2015 Q2	$6.03M	Buy	115,847 +4,342	+4%	+$244K	0.63%	40
2015 Q1	$6.43M	Buy	111,505 +5,797	+5%	+$332K	0.63%	39
2014 Q4	$5.65M	Sell	105,708 -3,956	-4%	-$221K	0.53%	45
2014 Q3	$6.3M	Buy	109,664 +3,998	+4%	+$245K	0.59%	41
2014 Q2	$7.06M	Buy	105,666 +5,388	+5%	+$365K	0.67%	32
2014 Q1	$6.7M	Buy	100,278 +285	+0.3%	+$19.3K	0.67%	34
2013 Q4	$6.67M	Sell	99,993 -3,981	-4%	-$258K	0.67%	33
2013 Q3	$6.52M	Sell	103,974 -20,152	-16%	-$1.3M	0.68%	35
2013 Q2	$7.75M	Buy	+124,126	New	+$7.88M	0.84%	27

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of Hawaii's GSK Position: Q1 2021 in Review

Bank of Hawaii sold out of GSK (GSK) in Q1 2021, closing a stake of 7,088 shares — an estimated $326K sold.

Bank of Hawaii first reported a position in GSK in Q2 2013 and held it in 31 quarters. The position peaked at $7.75M in Q2 2013. 775 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

Bank of Hawaii reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
Bank of Hawaii sold 7,088 GSK shares in Q1 2021, an estimated $326K.
Bank of Hawaii first reported a position in GSK in Q2 2013 and held it in 31 quarters.
Bank of Hawaii's GSK position peaked at $7.75M in Q2 2013.
775 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Bank of Hawaii's 13F filing for Q1 2021, filed 13 May 2021.